Insights on the Parenteral Nutrition Global Market to 2028 - by Nutrient Type, End-use and Region

Dublin, July 13, 2021 (GLOBE NEWSWIRE) -- The "Parenteral Nutrition Market Size, Share & Analysis, By Nutrient Type, By End-Use, And By Region, Global Forecast to 2028" report has been added to ResearchAndMarkets.com's offering.

The global parenteral nutrition market size is expected to reach USD 9,158.7 Million in 2028, and register a CAGR of 5.3% during the forecast period. Market growth is majorly driven by factors such as growing population of malnourished human beings, particularly in underdeveloped countries, rising number of premature births, increasing prevalence of various chronic diseases such as cancer and autoimmune diseases are resulting in need for administration of parenteral nutrition to patients who are unable eat by mouth or via tube feeding. Thus, driving adoption of parenteral nutrition technique and driving market growth.

Growing geriatric population, and adoption of parenteral nutrition technique to administer vital nutrients to elderly people in order to provide and maintain hydration levels, energy, and strength is another major factor driving growth of the global parenteral nutrition market. These nutrients include proteins, essential fats and carbohydrates, minerals, electrolytes, vitamins, and vital trace elements.

Possible side effects of over-consuming parenteral nutrition such as changes in heart rate, rapid weight loss or gain, seizures, fatigue, fever, chills, frequent urination, as well as memory loss could hamper consumption of parenteral nutrition and restrain market growth.

Some Key Findings From the Report:

  • Among the nutrition type segments, the single dose amino acid solutions segment accounted for the largest revenue share in 2020, due to growing number of health-conscious people, and prevalence of various chronic diseases at a global level. The lipid emulsion segment is expected to register a robust revenue CAGR during the forecast period.

  • Among the end-use segments, the hospital segment accounted for major revenue share in 2020, due to higher number of patient footfall in government or private hospitals as compared to other healthcare centers. The clinics segment is expected to register a robust revenue CAGR during the forecast period, owing to need for personal attention and care to be given to patients who need parenteral nutrition.

  • The North America parenteral nutrition market accounted for major revenue share in 2020, owing to increasing investments in research and development by government in countries in the region, along with privately-owned healthcare organizations, and regulatory authorities for manufacturing parenteral nutrition drugs.

  • The Asia Pacific market is expected to register a robust revenue CAGR during the forecast period.

  • Companies considered and profiled in the market report include Baxter International Inc., Grifols International S.A., Actavis Inc., B. Braun Melsungen AG, Fresenius Kabi AG, Hospira Inc., Claris Lifesciences Limited, Sichuan Kelun Pharmaceutical, Pfizer, and Aculife (Nirlife). The market players have adopted various strategies including mergers, acquisitions, partnerships, and new product developments, among other strategies, to stay ahead of the competition and expand market footprint.